<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The most frequently diagnosed <z:hpo ids='HP_0000726'>dementia</z:hpo> diseases include <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) and <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Cholinesterase (ChE) inhibitors and the <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> memantine are currently recommended as first line drugs for the treatment of AD </plain></SENT>
<SENT sid="2" pm="."><plain>These anti-<z:hpo ids='HP_0000726'>dementia</z:hpo> drugs have not yet been approved for the treatment of VD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> although the results of controlled clinical studies support the effectiveness of the ChE inhibitors for both diseases </plain></SENT>
<SENT sid="3" pm="."><plain>The treatment of the <z:e sem="disease" ids="C0277554" disease_type="Disease or Syndrome" abbrv="">primary disease</z:e> and the secondary prevention of <z:hpo ids='HP_0001297'>cerebrovascular accidents</z:hpo> constitute the primary objectives of VD therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Although single or multiple domain <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> are the clinical key symptoms of <z:hpo ids='HP_0000726'>dementia</z:hpo>, noncognitive psychopathological symptoms (so-called <z:hpo ids='HP_0000708'>behavioral disorders</z:hpo>) are particularly common and may even dominate the clinical course in the moderate to severe stages </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, it is important to recognize, diagnose and specifically treat these additional symptoms </plain></SENT>
<SENT sid="6" pm="."><plain>During the last decade, the classic <z:chebi fb="25" ids="35476">neuroleptics</z:chebi> and <z:chebi fb="13" ids="22720">benzodiazepine</z:chebi> have been largely replaced by modern antidepressants, atypical <z:chebi fb="0" ids="35476">antipsychotics</z:chebi> and <z:chebi fb="13" ids="22720">benzodiazepine</z:chebi> analogues </plain></SENT>
</text></document>